Unijules.com

Trade Products PDF Print E-mail
PRODUCT
INGREDIENTS
INDICATIONS
PACK
 Karela, Neem, Tulsi, Sounth, Guggul & Kutki Diabetes Supplement 100's
 Ashoka, Shatavari, Ashwagandha, Lodhra & Manjistha Uterine Tonic 200 ml / 500 ml
 Iron Choline Citrate, Zinc Sulphate & B'Complex General Restorative Tonic 210 ml
 Ferrous ascorbate & Folic acid Haematinic 150 ml
 Ferrous fumarate, Tricalcium phosphate, ZnSO4, Vit B12 & Folic acid Haematinic 3 x 10
 Chloroquine phosphate Anti-Malarial10 x 10
 Chloroquine phosphate Anti-Malarial60 ml
 Calcium lactate, Calcium gluconate, Vit. D3, Ferrous gluconate, Vit. B6, B12 & LysineGeneral Supplement for Children 110 ml
 Dextromethorphan, Ambroxol & Cetirizine For Dry Cough 60 ml
 Ambroxol, Guiaphenesine & Terbutalin For Wet Cough 100 ml
 Pseudoephedrine & Ibuprofen For UT Infection 10 x 10
 Paracetamol, CPM, Phenylephrine & Caffeine Anti-cold25 x 10
PARACODRATE Tablets Paracetamol, CPM, Phenylephrine & Caffeine Anti-cold25 x 10
 Di-sodium Hydrogen Citrate Systemic Alkalizer 100 ml
UNICAL Tablets Calcium carbonate, Vit D3, & Zinc sulphate Calcium Supplement5 x 2 x 10
 Clotrimazole, Beclomethasone & Neomycine For Skin Infections 15 g
 OfloxacinAntibiotics10 x 10
 OfloxacinAntibiotics5 x 2 x 10
 Ofloxacin & Ornidazole Antibiotics10 x 10
 ProgesteroneHormonal Supplement 2 ml
 ProgesteroneHormonal Supplement 4 ml
 HydroxyprogesteroneHormonal Supplement 1 ml
  HydroxyprogesteroneHormonal Supplement 1 ml
UNIFOL Inj.Folic acid, Nicotinamide & cyanocobalamin For Anaemia 10 ml
 Alpha beta arteether Anti-malarial2 ml
 Iron Sucrose Iron Supplement 2.5 ml / 5 ml
 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Allopathic Range arrow Trade Products
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.